Literature DB >> 26686446

Management of Interrupted Aortic Arch.

Richard A Jonas1.   

Abstract

The introduction of prostaglandin E1 in the late 1970s revolutionized the management of interrupted aortic arch. Complete resuscitation should proceed over several days if necessary before surgery is undertaken. One-stage primary neonatal repair with direct arch anastomosis and ventricular septal defect closure is the preferred surgical approach. Selective cerebral perfusion with near-infrared monitoring is being used with increasing frequency. Although repair of interrupted arch is physiologically corrective, it should not be viewed as fully corrective because of the high incidence of important late left ventricular outflow tract obstruction. This may respond to a simple surgical reintervention such as subaortic resection, but in some cases, an extensive procedure to enlarge the left ventricular outflow tract is necessary. However, procedures directed against subaortic stenosis should rarely be used as part of the initial surgical management during the neonatal period. Careful developmental follow-up is needed for all patients because of the high incidence of DiGeorge syndrome, which frequently manifests as moderately severe developmental delay.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  interrupted aortic arch; left ventricular outflow tract obstruction; one-stage surgical management

Mesh:

Substances:

Year:  2015        PMID: 26686446     DOI: 10.1053/j.semtcvs.2015.04.003

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  2 in total

1.  Interrupted right-sided aortic arch: performance of umbilical xenograft after primary neonatal corrective surgery.

Authors:  Jasmin H Shahinian; Daniel Tobler; Thomas Wolff; Martin Grapow
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

2.  Hybrid Strategy for High-Risk Neonates with Interrupted Aortic Arch: A Can Well Worth Kicking?

Authors:  Eva Kapravelou; David Anderson; Gareth J Morgan
Journal:  Int J Angiol       Date:  2017-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.